Sulfanitran|CAS 122-16-7|DC Chemicals

Cas No.:	122-16-7
Chemical Name:	Sulfanitran
Synonyms:	Acetamide,N-[4-[[(4-nitrophenyl)amino]sulfonyl]phenyl]-;N-[4-[(4-nitrophenyl)sulfamoyl]phenyl]acetamide;N\-ACETYL-NY(4-NITROPHENYL)SULFANILAMIDE;Sulfanitran;4-aminoacetyl-N-p-nitrophenylsulfanilamide;APNPS;component of Novastat;component of Polystat;component of Unistat;N4-Acetyl-N1-(4-nitrophenyl)sulfanilamide;N4-ACETYL-N1-(4-NITROPHENYL)-SULFANILAMIDE;WAKO195-17011;NSC-77120;NSC 217299;Sulfanitran solution,100ppm;N4-Acetyl-4'-nitrosulfanilanilide;ACETYL[P-NITROPHENYL]SULFANILAMIDE;sulfanitran85+%;sulfanitranapprox.85%;sulfanitran approx. 85%;N(sup4)-Acetyl-4'-nitrosulfanilanilide;4'-((p-Nitrophenyl)sulfamoyl)acetanilide;QT35T5T35Q;Acetyl(p-nitrophenyl)sulfanilamide;NSC77120;NSC217299;N(sup4)-Acetyl-N(sup1)-(p-nitrophenyl)sulfanilamide;N(sup4)-Acetyl-N(sup1)-(4-nitrophenyl)sulfanilamide;DSSTox_CID_25898;DSSTox_RID_81210;DSSTox_GSID_45898;Acetamide, N-(4-(((4-nitrop;C71835;SR-05000001857-1;SPECTRUM1503339;HY-B0947;D05951;Acetanilide, 4'-((p-nitrophenyl)sulfamoyl)-;Sulfanitran, VETRANAL(TM), analytical standard;DivK1c_000830;CCG-213164;Tox21_111401_1;J-004768;Tox21_111401;MFCD00024598;GWBPFRGXNGPPMF-UHFFFAOYSA-N;KBio2_002173;N-[4-[[(4-Nitrophenyl)a-mino]sulfonyl]phenyl-13C6]acetamide;Sulfanitrano;KBio3_002710;DB11463;Spectrum3_001755;MLS004774076;NSC-758458;NCGC00095045-05;1353867-79-4;BDBM50248248;UNISTAT 2 COMPONENT SULFANITRAN;NCGC00095045-01;N(4)-Acetyl-4'-nitrosulfanilanilide;KBio2_004741;N-(4-(N-(4-nitrophenyl)sulfamoyl)phenyl)acetamide;Spectrum5_001477;FT-0631698;DTXCID2025898;AKOS003980372;N-(4-[(4-Nitroanilino)sulfonyl]phenyl)acetamide #;NSC 77120;SR-05000001857;SULFANITRAN [INN];N(4)-Acetyl-N(1)-(p-nitrophenyl)sulfanilamide;SBI-0052913.P002;Sulfanitran, ~85%;NS00000186;NSC-217299;CHEBI:114204;Sulfanitran [USAN:INN:BAN];CHEMBL493636;Acetamide, N-(4-(((4-nitrophenyl)amino)sulfonyl)phenyl)-;CS-4420;HMS1922A20;Acetamide, N-[4-[[ (4-nitrophenyl)amino]sulfonyl]phenyl]-;SMR003500745;SCHEMBL93837;Sulfanitran (USAN/INN);Sulfanitrano [INN-Spanish];KBio1_000830;SULFANITRAN [MI];sulfanitran;NSC758458;Q27195401;Acetanilide, 4'-[(p-nitrophenyl)sulfamoyl]-;BRD-K76845197-001-01-3;SR-05000001857-3;Pharmakon1600-01503339;CAS-122-16-7;NINDS_000830;BSPBio_003490;KBio2_007309;N4-ACETYL-N1-(4-NITROPHENYL)-SULFANILAMIDE, TECH.;AB00052349_02;KBioSS_002173;IDI1_000830;Sulfanitranum;BS-14665;Spectrum_001693;DTXSID4045898;SULFANITRAN [MART.];HMS2093E09;KBioGR_001495;SULFANITRAN [GREEN BOOK];4'-[(p-Nitrophenyl)sulfamoyl]acetanilide;SULFANITRAN [USAN];UNII-QT35T5T35Q;122-16-7;NCGC00095045-03;Sulfanitranum [INN-Latin];HMS502J12;Spectrum4_000858;Oprea1_470804;Acetamide, N-[4-[[(4-nitrophenyl)amino]sulfonyl]phenyl]-;NCGC00095045-02;N-{4-[(4-nitrophenyl)sulfamoyl]phenyl}acetamide;DA-58178;BRD-K76845197-001-05-4;DB-041653;Sulfanitran-13C6;N4-Acetyl-N1-(4-nitrophenyl)-sulfanilamide;STL139243;SULFANITRAN
SMILES:	S(C1C([H])=C([H])C(=C([H])C=1[H])N([H])C(C([H])([H])[H])=O)(N([H])C1C([H])=C([H])C(=C([H])C=1[H])[N+](=O)[O-])(=O)=O
Formula:	C₁₄H₁₃N₃O₅S
M.Wt:	335.3351
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.